glp 1 receptor agonist moa GLP-1 agonists (GLP-1RAs): cardiovascular actions and therapeutic potential Weight Loss and Maintenance Related
Description
This information will help reduce the risk of any drug interactions or adverse reactions
N Engl J Med 2013
J Am Coll Cardiol 2024;84:696-708.ArticlePubMed 83
It undergoes enzymatic processing from its preproglucagon peptide precursor within intestinal L-cells, ultimately giving rise to GLP-1(1-37) and peptide variants including GLP-1(7-36)
This higher dose is specifically designed to enhance its weight loss effects
Li concluded, stating that their results indicate a potential lithoprotective benefit from GLP-1A use in obese, at-risk populations
